JAK2/STAT5 signaling pathway mediates Bojungbangdocktang enhanced hematopoiesis

Phytotherapy Research

Volumn 25, Issue 3, 2011, Pages 329-337

  Lim, Jeonghan ^a   Jeong, Soo Jin ^a   Koh, Wonil ^a   Han, Ihn ^a   Lee, Hyo Jung ^a   Kwon, Tae Rin ^a   Jung, Ji Hoon ^a   Kim, Jung Hyo ^b   Lee, Hyo Jeong ^a   Lee, Eun Ok ^a   Kim, Sun Hyung ^a   Lee, Min Ho ^a   Kim, Sung Hoon ^a  

^a Kyung Hee University   (South Korea)

^b Chosun Nursing College   (South Korea)

Author keywords

Bojungbangdocktang; Hematopoiesis; Hematopoietic cytokines; JAK2 STAT5

Indexed keywords

BENZENE; BLOOD GROUP ANTIGEN; BOJUNGBANGDOCKTANG; ERYTHROID SPECIFIC ANTIGEN; ERYTHROPOIETIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; JANUS KINASE 2; MESSENGER RNA; PLANT MEDICINAL PRODUCT; STAT5 PROTEIN; STEM CELL FACTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APLASTIC ANEMIA; ARTICLE; BINDING SITE; BONE MARROW CELL; BURST FORMING UNIT E; COLONY FORMING UNIT GEMM; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; ERYTHROID CELL; GAMMA INTERFERON ACTIVATED SITE; GRANULOCYTE ERYTHROCYTE MONOCYTE MACROPHAGE; GROWTH RATE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTOCHEMISTRY; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROTEIN BINDING; SIGNAL TRANSDUCTION; STROMA CELL;

ANEMIA, APLASTIC; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; FIBROBLASTS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; JANUS KINASE 2; LEUKOCYTES, MONONUCLEAR; LUNG; MALE; MEDICINE, KOREAN TRADITIONAL; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; STAT5 TRANSCRIPTION FACTOR;

MUS;

EID: 79952224818     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3257     Document Type: Article

References (49)

1. Al-Shohaib S, Shaker DS, Ghaedi BB, Alyarim M, Emara S, Behairy M. 2010. The hematopoietic effect of Epotin (recombinant human erythropoietin-alpha) on maintenance hemodialysis end-stage kidney disease patients. Transplant Proc 42: 753-759.
2. Allen TD, Dexter TM. 1984. The essential cells of the hemopoietic microenvironment. Exp Hematol 12: 517-521. (Pubitemid 14059521)
3. Appelbaum FR, Fefer A, Cheever MA et al. 1980. Treatment of aplastic anemia by bone marrow transplantation in identical twins. Blood 55: 1033-1039. (Pubitemid 10063381)
4. Banu N, Wang JF, Deng B, Groopman JE, Avraham H. 1995. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood 86: 1331-1338.
5. Brugger W, Mocklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. 1993. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 81: 2579-2584. (Pubitemid 23147560)
6. Camitta BM, Storb R, Thomas ED. 1982a. Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 306: 645-652.
7. Camitta BM, Storb R, Thomas ED. 1982b. Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 306: 712-718.
8. Chen D, Wang SL, Wang YP. 2003. [Experimental study on expression of GM-CSF from human endothelial cells and monocytes induced by total saponins of panax ginseng]. Zhongguo Zhong Xi Yi Jie He Za Zhi 23: 845-847.
9. Chen D, Zuo G, Li C et al. 2009. Total saponins of Panax ginseng (TSPG) promote erythroid differentiation of human CD34+ cells via EpoR-mediated JAK2/STAT5 signaling pathway. J Ethnopharmacol 126: 215-220.
10. Cohen HS, Freedman ML, Goldstein BD. 1978. The problem of benzene in our environment: clinical and molecular considerations. Am J Med Sci 275: 124-136.
11. Cui Y, Riedlinger G, Miyoshi K et al. 2004. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 24: 8037-8047. (Pubitemid 39167454)
12. Currier NL, Miller SC. 2001. Echinacea purpurea and melatonin augment natural-killer cells in leukemic mice and prolong life span. J Altern Complement Med 7: 241-251. (Pubitemid 32574896)
13. Dai CH, Krantz SB, Zsebo KM. 1991. Human burst-forming unitserythroid need direct interaction with stem cell factor for further development. Blood 78: 2493-2497.
14. Deans RJ, Moseley AB. 2000. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28: 875-884.
15. Denizot Y, Praloran V. 1994. PAF and haematopoiesis. I. 5-Fluoro-uracil induces PAF production in haematopoietic organs of rats. Mediators Inflamm 3: 23-25.
16. Fang GL, Gao RL, Lin XJ, Jin JM. 2007. [Effects of Ginseng panaxadiol saponin on proliferation and differentiation of human bone marrow CD34+ cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15: 776-779.
17. Gardner RV. 1999. Long term hematopoietic damage after chemotherapy and cytokine. Front Biosci 4: e47-e57.
18. Gardner RV, McKinnon E, Poretta C, Leiva L. 2003. Hemopoietic function after use of IL-1 with chemotherapy or irradiation. J Immunol 171: 1202-1206. (Pubitemid 36900048)
19. Grebien F, Kerenyi MA, Kovacic B et al. 2008. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. Blood 111: 4511-4522.
20. Guerriero A, Worford L, Holland HK, Guo GR, Sheehan K, Waller EK. 1997. Thrombopoietin is synthesized by bone marrow stromal cells. Blood 90: 3444-3455. (Pubitemid 27473414)
21. Harnack U, Eckert K, Fichtner I, Pecher G. 2010. Comparison of the effect of orally administered soluble beta-(1-3),(1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis. In Vivo 24: 59-63.
22. Haznedaroglu IC, Arici M, Buyukasik Y. 2000. A unifying hypothesis for the renin - angiotensin system and hematopoiesis: sticking the pieces together with the JAK-STAT pathway. Med Hypotheses 54: 80-83. (Pubitemid 30156641)
23. Huang H, Rose JL, Hoyt DG. 2004. p38 Mitogen-activated protein kinase mediates synergistic induction of inducible nitricoxide synthase by lipopolysaccharide and interferongamma through signal transducer and activator of transcription 1 Ser727 phosphorylation in murine aortic endothelial cells. Mol Pharmacol 66: 302-311. (Pubitemid 38989487)
24. Jang YS, Lee EO, Lee HJ et al. 2009. Bojungbangdocktang inhibits vascular endothelial growth factor induced angiogenesis via blocking the VEGF/VEGFR2 signaling pathway in human umbilical vein endothelial cells. Chin Sci Bull 54: 227-233.
25. Jiang C, Lee HJ, Li GX et al. 2006. Potent antiandrogen and androgen receptor activities of an Angelica gigascontaining herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. Cancer Res 66: 453-463. (Pubitemid 43166054)
26. Kang SH, Lee HJ, Jeong SJ et al. 2009. Protective effect of Bojungbangdocktang on cisplatin-induced cytotoxicity and apoptosis in MCF-10A breast endothelial cells. Environ Toxicol Pharmacol 28: 430-438.
27. Kaushansky K, Broudy VC, Lin N et al. 1995. Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 92: 3234-3238.
28. Kaushansky K, Lok S, Holly RD et al. 1994. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369: 568-571. (Pubitemid 24192526)
29. Lee BW, Song HJ, Kim SH. 1994. Experimental study on antitumor and immunoenhancing activities of Bangdoktang. J Oriental Pathol 15: 263-281.
30. Lee HJ, Kim KH, Jang YS. 2007. Protective effect of ethanol extract of Bojungbangamtang on cisplatin induced toxicity. J Oriental Pathol 21: 1-5.
31. Lee J, Shin JS, Park JY et al. 2003. p38 mitogen-activated protein kinase modulates expression of tumor necrosis factor-related apoptosis-inducing ligand induced by interferon-gamma in fetal brain astrocytes. J Neurosci Res 74: 884-890. (Pubitemid 37490421)
32. Lu L, Jia XQ. 2000. Effects of naturin 2 on colony formation by hematopoietic progenitor cells in human umbilical cord blood mediated by induction of release of growth factors. In Vivo 14: 441-446. (Pubitemid 30433372)
33. Lv Y, Feng X, Zhu B. 2005. [Study on effect of Astragalus membranaceus injection on hematopoiesis in anemic mice with myelosuppression]. Zhong Yao Cai 28: 791-793.
34. Macdougall IC. 2008. Novel erythropoiesis-stimulating agents: a new era in anemia management. Clin J Am Soc Nephrol 3: 200-207.
35. Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN. 1997. Role of Janus Kinase/Signal Transducer and Activator of Transcription and Mitogen-activated Protein Kinase Cascades in Angiotensin II- and Platelet-derived Growth Factorinduced Vascular Smooth Muscle Cell Proliferation. J Biol Chem 272: 24684-24690. (Pubitemid 27418687)
36. Metcalf D. 2008. Hematopoietic cytokines. Blood 111: 485-491.
37. Nosaka T, Kitamura T. 2000. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells. Int J Hematol 71: 309-319.
38. Otani T, Nakamura S, Inoue T et al. 2004. Erythroblasts derived in vitro from embryonic stem cells in the presence of erythropoietin do not express the TER-119 antigen. Exp Hematol 32: 607-613. (Pubitemid 38891529)
39. Ramana CV, Grammatikakis N, Chernov M et al. 2000. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J 19: 263-272. (Pubitemid 30042708)
40. Rinsky RA, Smith AB, Hornung R et al. 1987. Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med 316: 1044-1050. (Pubitemid 17047292)
41. Si J, Collins SJ. 2002. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner. Blood 100: 4401-4409. (Pubitemid 35429678)
42. Singh SM, Singh N, Shrivastava P. 2006. Effect of alcoholic extract of Ayurvedic herb Tinospora cordifolia on the proliferation and myeloid differentiation of bone marrow precursor cells in a tumor-bearing host. Fitoterapia 77: 1-11. (Pubitemid 43011356)
43. Slovak ML, Bedell V, Lew D et al. 2010. Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012). Breast Cancer Res Treat 119: 391-398.
44. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF. 2001. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98: 3261-3273.
45. Sytkowski AJ. 2007. Does erythropoietin have a dark side? Epo signaling and cancer cells. Sci STKE pe38.
46. Uddin S, Lekmine F, Sassano A, Rui H, Fish EN, Platanias LC. 2003. Role of Stat5 in type I interferon-signaling and transcriptional regulation. Biochem Biophys Res Commun 308: 325-330. (Pubitemid 36937183)
47. Vignais ML, Sadowski HB, Watling D, Rogers NC, Gilman M. 1996. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol 16: 1759-1769. (Pubitemid 26095648)
48. Zhu X, Zhu B. 2001. [Effect of Astragalus membranaceus injection on megakaryocyte hematopoiesis in anemic mice]. Hua Xi Yi Ke Da Xue Xue Bao 32: 590-592.
49. Zhu XL, Zhu BD. 2007. Mechanisms by which Astragalus membranaceus injection regulates hematopoiesis in myelosuppressed mice. Phytother Res 21: 663-667.